1228784-08-4

Usage

Appearance

White to off-white crystalline powder

Solubility

Insoluble in water, soluble in organic solvents

Uses

Intermediate in the synthesis of pharmaceuticals and agrochemicals, manufacture of perfumes and other fragrances

Properties

Insecticidal and antifungal

Potential applications

Development of new agricultural pesticides

Safety precautions

Handle with care, may be hazardous if not used properly

Upstream product

• 93493-95-9 2-{[(trifluoromethyl)sulfonyl]oxy}cyclohex-1-enecarboxylic acid methyl ester 
• 108-94-1 cyclohexanone 
• 41302-34-5 2-(methoxycarbonyl)cyclohexanone 
• 1228784-07-3 ethyl 2-(4-chlorophenyl)cyclohex-1-enecarboxylate 

Downstream Products

• 1228784-09-5 2-(4-chlorophenyl)cyclohex-1-ene-1-carbaldehyde 

Relevant academic research and scientific papers

Novel BCL-2/BCL-XL inhibitor, pharmaceutical composition and application

The invention relates to a compound for inhibiting the activity of Bcl-2/BCL-XL anti-apoptotic protein, a composition containing the compound and application of the compound serving as a synthetic drug, in particular to application of the compound serving as a drug for synthesizing a Bcl-2/BCL-XL anti-apoptotic protein inhibitor and application of the compound to cancer.

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.